Cheng Ji

2.3k total citations · 2 hit papers
41 papers, 1.8k citations indexed

About

Cheng Ji is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Cheng Ji has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Nephrology and 7 papers in Cancer Research. Recurrent topics in Cheng Ji's work include Extracellular vesicles in disease (19 papers), MicroRNA in disease regulation (6 papers) and Mesenchymal stem cell research (5 papers). Cheng Ji is often cited by papers focused on Extracellular vesicles in disease (19 papers), MicroRNA in disease regulation (6 papers) and Mesenchymal stem cell research (5 papers). Cheng Ji collaborates with scholars based in China, United States and United Kingdom. Cheng Ji's co-authors include Hui Qian, Wenrong Xu, Hui Shi, Xu Zhang, Peipei Wu, Siqi Yin, Yongmin Yan, Fei Mao, Bin Zhang and Yaoxiang Sun and has published in prestigious journals such as ACS Nano, Scientific Reports and Journal of the American Society of Nephrology.

In The Last Decade

Cheng Ji

39 papers receiving 1.8k citations

Hit Papers

Human Mesenchymal Stem Cell Derived Exosomes Alleviate Ty... 2018 2026 2020 2023 2018 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Ji China 19 1.2k 492 278 217 212 41 1.8k
Mujib Ullah United States 24 1.1k 0.9× 459 0.9× 444 1.6× 308 1.4× 124 0.6× 63 2.0k
Dinender K. Singla United States 30 1.5k 1.3× 305 0.6× 254 0.9× 648 3.0× 167 0.8× 76 2.5k
Yueh Chien Taiwan 32 1.6k 1.4× 639 1.3× 191 0.7× 246 1.1× 180 0.8× 102 2.6k
Yu‐Ting Huang Taiwan 26 728 0.6× 230 0.5× 143 0.5× 466 2.1× 179 0.8× 75 2.5k
Zhenzhen Jiang China 18 692 0.6× 354 0.7× 80 0.3× 217 1.0× 100 0.5× 61 1.4k
Roberto F. Nicosia United States 25 1.3k 1.1× 478 1.0× 153 0.6× 357 1.6× 69 0.3× 51 2.5k
Ciarán O’Neill United Kingdom 20 1.2k 1.0× 558 1.1× 232 0.8× 308 1.4× 106 0.5× 33 1.9k
Weiquan Zhu China 20 889 0.8× 226 0.5× 317 1.1× 254 1.2× 215 1.0× 42 2.1k
Tao Ma United States 25 934 0.8× 386 0.8× 269 1.0× 290 1.3× 141 0.7× 69 2.2k
Zhenhong Ni China 21 1.8k 1.5× 849 1.7× 147 0.5× 229 1.1× 410 1.9× 43 2.6k

Countries citing papers authored by Cheng Ji

Since Specialization
Citations

This map shows the geographic impact of Cheng Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Ji more than expected).

Fields of papers citing papers by Cheng Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Ji. The network helps show where Cheng Ji may publish in the future.

Co-authorship network of co-authors of Cheng Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Ji. A scholar is included among the top collaborators of Cheng Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Ji. Cheng Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bei, et al.. (2025). Therapeutic Potential of hucMSC‐EVs in Diabetic Kidney Disease via Regulating the miR‐146b‐5p/Merlin/YAP Axis. Stem Cells International. 2025(1). 5243270–5243270.
2.
Li, Bei, Wei Wu, Wenrong Xu, Hui Qian, & Cheng Ji. (2025). Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application. Journal of Nanobiotechnology. 23(1). 678–678. 2 indexed citations
3.
Jin, Can, Peipei Wu, Wei Wu, et al.. (2025). Therapeutic role of hucMSC-sEV-enriched miR-13896 in cisplatin-induced acute kidney injury through M2 macrophage polarization. Cell Biology and Toxicology. 41(1). 50–50. 8 indexed citations
4.
Ji, Cheng, et al.. (2024). Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine. 9(1). 3–3. 16 indexed citations
5.
Wang, Min, Dakai Yang, Peipei Wu, et al.. (2024). A Dual Role of Mesenchymal Stem Cell Derived Small Extracellular Vesicles on TRPC6 Protein and Mitochondria to Promote Diabetic Wound Healing. ACS Nano. 18(6). 4871–4885. 26 indexed citations
6.
Hu, Yu‐Yan, Hui Shi, Wenrong Xu, et al.. (2024). Mesenchymal stem cell-derived extracellular vesicles ameliorate renal interstitial fibrosis via the miR-13474/ADAM17 axis. Scientific Reports. 14(1). 17703–17703. 10 indexed citations
7.
Li, Bei, Qi Chen, Yifan Zhang, et al.. (2024). Frontier role of extracellular vesicles in kidney disease. Journal of Nanobiotechnology. 22(1). 583–583. 13 indexed citations
8.
Zheng, Danna, et al.. (2024). MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4. World Journal of Diabetes. 15(3). 488–501. 2 indexed citations
9.
Chen, Wenya, et al.. (2024). Extracellular vesicles: Illuminating renal pathophysiology and therapeutic frontiers. European Journal of Pharmacology. 978. 176720–176720. 1 indexed citations
10.
Zhou, Zixuan, et al.. (2023). Implications of Crosstalk between Exosome-Mediated Ferroptosis and Diseases for Pathogenesis and Treatment. Cells. 12(2). 311–311. 21 indexed citations
11.
Yin, Siqi, Zixuan Zhou, Peiwen Fu, et al.. (2023). Roles of extracellular vesicles in ageing-related chronic kidney disease: Demon or angel. Pharmacological Research. 193. 106795–106795. 12 indexed citations
12.
Huang, Xiaojuan, Yan Wang, Hui‐Ting Wang, et al.. (2023). Exosomal hsa_circ_000200 as a potential biomarker and metastasis enhancer of gastric cancer via miR-4659a/b-3p/HBEGF axis. Cancer Cell International. 23(1). 151–151. 15 indexed citations
13.
Yin, Siqi, Wanzhu Liu, Cheng Ji, et al.. (2022). hucMSC‐sEVs‐Derived 14‐3‐3ζ Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 3281896–3281896. 12 indexed citations
14.
Shi, Hui, Yaoxiang Sun, Cheng Ji, et al.. (2021). 3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs. Frontiers in Oncology. 11. 603533–603533. 17 indexed citations
15.
Sun, Yaoxiang, Hui Shi, Siqi Yin, et al.. (2018). Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 12(8). 7613–7628. 354 indexed citations breakdown →
16.
Zhang, Rongxue, Lei Yin, Bin Zhang, et al.. (2018). Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death and Disease. 9(10). 965–965. 42 indexed citations
17.
Wang, Bingying, Haoyuan Jia, Bin Zhang, et al.. (2017). Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Research & Therapy. 8(1). 75–75. 129 indexed citations
18.
Ji, Cheng, Li Zhang, Yan Cheng, et al.. (2014). Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer. Cancer Biology & Therapy. 15(5). 570–577. 66 indexed citations
19.
Li, Xia, et al.. (2013). Acid-sensing ion channel 1a-mediated calcium influx regulates apoptosis of endplate chondrocytes in intervertebral discs. Expert Opinion on Therapeutic Targets. 18(1). 1–14. 79 indexed citations
20.
Kaplowitz, Neil, Tin Aung Than, Masao Shinohara, & Cheng Ji. (2007). Endoplasmic Reticulum Stress and Liver Injury. Seminars in Liver Disease. 27(4). 367–377. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026